Clinical Trials Logo

Artificial Intelligence clinical trials

View clinical trials related to Artificial Intelligence.

Filter by:

NCT ID: NCT04551235 Recruiting - Acute Leukemia Clinical Trials

Establishing Automatic Method of Counting and Classify Bone Marrow and Peripheral Blood Cells

Start date: August 28, 2020
Phase:
Study type: Observational

Counting and classification of blood cells in a bone marrow smear and peripheral blood smear are essential to clinical hematology. To this date, this procedure has been carried out in a manual manner in the great majority of clinical settings. There is often inconsistency in the counting result between different operators largely due to its manual nature. There has not been an effective and standard method for blood smear preparation and automatic counting and classification. The recent advent of deep neural network for medical image processing introduced new opportunities for an effective solution of this long-standing problem. Numerous results have been published on the effectiveness of convolutional neural network in clinical image recognition task.

NCT ID: NCT04547673 Recruiting - Clinical trials for Artificial Intelligence

To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma

Start date: June 20, 2020
Phase:
Study type: Observational

Nasopharyngeal carcinoma (NPC) occurs at a high frequency in southern China, northern Africa, and Alaska, with a reported incidence of 30 cases per 100 000 in Guangdong Province. Endoscopic examination and biopsy are the main methods used for detection and diagnosis of NPC. Early NPC patients achieve favourable prognoses after concurrent radiotherapy and chemotherapy in compassion with advanced NPC patients. Here, the investigators focused on the utility of artificial intelligence to detect early NPC, which based on white light imaging (WLI) and Narrow-band imaging (NBI) nasoendoscopic examination. Having access to this unique population provides an unprecedented opportunity to investigate the effect of intelligent system on diverse nasopharyngeal lesions detection and develop a novel Computer-Aided Diagnosis System.

NCT ID: NCT04541251 Recruiting - Clinical trials for Artificial Intelligence

Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC

Start date: August 1, 2020
Phase: Phase 2
Study type: Interventional

This prospective, single-arm, multicenter, phase II trial enrolled 40 patients who underwent surgery after three cycles of neoadjuvant therapy with camrelizumab, nab-paclitaxel, and carboplatin. The MPR is the primary endpoint, and the pCR, the complete resection rate, the objective response rate, the disease-free survival, adverse events, and quality of life are the secondary endpoints. The exploratory endpoints will be used to establish a multiomics artificial intelligence system for neoadjuvant therapy effect prediction and decision-making assistance based on radiomics, metabolism, genetic, and clinic-pathological characteristics and to explore drug resistance mechanisms.

NCT ID: NCT04535466 Recruiting - Clinical trials for Artificial Intelligence

Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics

Start date: September 1, 2020
Phase:
Study type: Observational [Patient Registry]

It is a prospective, observational cohort study of patients with dense breast tissue. The study was based on the radiomics and other clinicopathological information of patients to establish the diagnostic system for breast disease by using artificial intelligence.

NCT ID: NCT04419545 Recruiting - Clinical trials for Artificial Intelligence

Covid Radiographic Images Data-set for A.I

CORDA
Start date: March 24, 2020
Phase:
Study type: Observational

The possibility to use widespread and simple chest X-ray (CXR) imaging for early screening of COVID-19 patients is attracting much interest from both the clinical and the Artificial intelligence community. In this study we provide insights and also raise warnings on what is reasonable to expect by applying deep learning to COVID classification of CXR images. We provide a methodological guide and critical reading of an extensive set of statistical results that can be obtained using currently available datasets. In particular, we take the challenge posed by current small size COVID data and show how significant can be the bias introduced by transfer-learning using larger public non- COVID CXR datasets. We also contribute by providing results on a medium size COVID CXR dataset, just collected by one of the major emergency hospitals in Northern Italy during the peak of the COVID pandemic. These novel data allow us to contribute to validate the generalization capacity of preliminary results circulating in the scientific community. Our conclusions shed some light into the possibility to effectively discriminate COVID using CXR.

NCT ID: NCT04216901 Recruiting - Clinical trials for Artificial Intelligence

A Single Center Study on the Effectiveness and Safety of Polyp Classification With Artificial Intelligence

Start date: December 24, 2019
Phase:
Study type: Observational

This is an artificial intelligence-based optical endoscopic polyp diagnosis system that can assist endoscopic doctors in diagnosing polyps and improve the quality of training in clinical Settings.

NCT ID: NCT04138771 Recruiting - Cataract Clinical Trials

Validation of an Artificial Intelligence System for Postoperative Management of Cataract Patients

Start date: January 1, 2013
Phase: N/A
Study type: Interventional

Cataract surgery is the current standard of management for cataract patients, which is typically succeeded by a postoperative follow-up schedule. Here, the investigators established and validated an artificial intelligence system to achieve automatic management of postoperative patients based on analyses of visual acuity, intraocular pressure and slit-lamp images. The management strategy can also change according to postoperative time.

NCT ID: NCT04136236 Recruiting - Clinical trials for Artificial Intelligence

Automatic Diagnosis of Early Esophageal Squamous Neoplasia Using pCLE With AI

Start date: August 1, 2019
Phase:
Study type: Observational

Detection and differentiation of esophageal squamous neoplasia (ESN) are of value in improving patient outcomes. Probe-based confocal laser endomicroscopy (pCLE) can diagnose ESN accurately.However this requires much experience, which limits the application of pCLE. The investigators designed a computer-aided diagnosis program using deep neural network to make diagnosis automatically in pCLE examination and contrast its performance with endoscopists.

NCT ID: NCT04131530 Recruiting - Ulcerative Colitis Clinical Trials

Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence

Start date: October 2019
Phase:
Study type: Observational

Probe-based confocal laser endomicroscopy (pCLE) is an endoscopic technique that enables to evaluate the inflammation activity of ulcerative colitis with excellent correlation with histopathology. However this requires much experience, which limits the application of pCLE. The investigators designed a computer-aided diagnosis program using deep neural network to make diagnosis automatically in pCLE examination and contrast its performance with endoscopists.

NCT ID: NCT04126265 Recruiting - Colonoscopy Clinical Trials

Artificial Intelligence-assisted Colonoscopy for Detection of Colon Polyps

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

All subjects shall sign informed consent before screening, and subjects shall be included according to inclusion and exclusion criteria. A total of four endoscopists were included in the study, two in each group of senior endoscopists and two in each group of junior endoscopists. Patients were randomly enrolled into the senior endoscopy group and the junior endoscopy group, and received artificial intelligence assisted colonoscopy and conventional colonoscopy successively. The two colonoscopy methods were performed back to back by different endoscopy physicians with the same seniority. All patients were examined and treated according to routine medical procedures. The routine colonoscopy group and the artificial-intelligence-assisted colonoscopy group made detailed records of the patients' withdrawal time, entry time, number of polyps detected, polyp Paris classification, polyp size, polyp shape, polyp location and intestinal preparation during the colonoscopy process